The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Describe the role of colonic fermentation products in reducing the risk for colon cancer and liver disease
Explain how SLC5A8 (a transporter for short-chain fatty acids) and GPR109A (a receptor for butyrate) mediate the tumorsuppressive functions of colonic fermentation products
Relate how the gut microbiota and its metabolic byproducts influence liver pathology
Speaker(s):
Gail
Cresci,
PhD, RD,
Director, Nutrition Research, Center for Human Nutrition, Digestive Disease & Surgery Institute,
Cleveland Clinic, Cleveland, OH